Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA05.050a, Eye Prostheses and Scleral Cover Shell
Notification: 03/08/2017 | Effective: 04/07/2017 | Posted: 03/08/2017
Type of policy change: Medical Necessity Criteria

MA06.029, Therapeutic Drug Monitoring for Antidepressants, Antipsychotics or Antiepileptics
Notification: 03/08/2017 (revised 03/28/2017) | Effective: 04/07/2017 | Posted: 03/08/2017
Type of policy change: This is a new policy.

MA11.036c, Surgical Treatment of Nails
Notification: 03/22/2017 | Effective: 04/21/2017 | Posted: 03/22/2017
Type of policy change: Medical Coding


New Policies
The following Medicare Advantage policies have been newly developed to communicate coverage and/or reimbursement positions, reporting requirements, and other processes and procedures for doing business with Independence Blue Cross.
MA06.024, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Effective: 03/01/2017 | Posted: 03/01/2017
Type of policy change: This is a new policy.

MA08.083, Gonadotropin-Releasing Hormone Agonist (Eligard®, Lupron Depot®)
Notification: 12/14/2016 | Effective: 03/14/2017 | Posted: 03/14/2017
Type of policy change: This is a new policy.


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA00.005i, Experimental/Investigational Services
Effective: 03/01/2017 | Posted: 03/01/2017
Type of policy change: Medical Coding

MA07.025b, Intrauterine Systems (IUSs) (e.g., Mirena®, Skyla®, Liletta®, Kyleena®)
Effective: 03/08/2017 | Posted: 03/08/2017
Type of policy change: Medical Coding; General Description, Guidelines, or Informational Update

MA08.056b, Eribulin Mesylate (Halaven™)
Effective: 03/08/2017 | Posted: 03/08/2017
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA08.019b, Infliximab and related biosimilars
Effective: 03/08/2017 | Posted: 03/09/2017
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA05.052b, Canes and Crutches
Notification: 02/08/2017 | Effective: 03/10/2017 | Posted: 03/10/2017
Type of policy change: Coverage and/or Reimbursement Position

MA08.052c, Denosumab (Prolia®, Xgeva®)
Notification: 12/15/2016 | Effective: 03/14/2017 | Posted: 03/14/2017
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

MA05.025a, Pressure-Reducing Support Surfaces
Effective: 03/22/2017 | Posted: 03/22/2017
Type of policy change: General Description, Guidelines, or Informational Update

MA05.036b, Commode Chairs
Notification: 02/22/2017 | Effective: 03/24/2017 | Posted: 03/24/2017
Type of policy change: Coverage and/or Reimbursement Position

MA05.047b, Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring in Adults
Notification: 02/24/2017 | Effective: 03/24/2017 | Posted: 03/24/2017
Type of policy change: Medical Coding; General Description, Guidelines, or Informational Update

MA08.073c, Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists (e.g., ranibizumab [Lucentis®], pegaptanib sodium [Macugen®], aflibercept [Eylea®])
Notification: 12/28/2016 | Effective: 03/28/2017 | Posted: 03/28/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA05.022, Home-Use Light Box for the Treatment of Seasonal Affective Disorder (SAD)
Reissue Effective: 03/01/2017 | Reissue Posted: 03/02/2017

MA07.002b, Ultraviolet Light Therapy for the Treatment of Dermatological Conditions
Reissue Effective: 03/01/2017 | Reissue Posted: 03/02/2017

MA07.036b, Low-Level Laser Therapy
Reissue Effective: 03/01/2017 | Reissue Posted: 03/02/2017

MA07.056a, Photodynamic Therapy (PDT) Using Levulan® Kerastick® (Aminolevulinic Acid HCl [ALA]) or Metvixia® (Methyl Aminolevulinate [MAL])
Reissue Effective: 03/01/2017 | Reissue Posted: 03/02/2017

MA11.071a, Selective Photothermolysis Using Pulsed-Dye Lasers (PDL)
Reissue Effective: 03/01/2017 | Reissue Posted: 03/02/2017

MA05.019, Continuous Passive Motion (CPM) Devices in the Home Setting
Reissue Effective: 03/15/2017 | Reissue Posted: 03/15/2017

MA05.055, Standing Frames
Reissue Effective: 03/15/2017 | Reissue Posted: 03/15/2017

MA05.064, Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)
Reissue Effective: 03/29/2016 | Reissue Posted: 03/29/2017

MA11.022a, Cryosurgical Ablation of the Prostate Gland
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017

MA05.042a, Pulse Oximeters in the Home Setting
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017

MA05.065, Transtympanic Micropressure Device as a Treatment of Meniere Disease
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017

MA07.005a, Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) Devices
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017

MA11.110, Surgery for Gynecomastia
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017

MA11.069a, Reduction Mammoplasty
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017

MA11.042a, Revision of a Previous Cosmetic Procedure
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017

MA11.076c, Removal of Breast Implants
Reissue Effective: 03/29/2017 | Reissue Posted: 03/29/2017










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.